Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

March 22, 2023

Time to educate patients about biosimilars?

  • MS Drug Therapies
    /
 March 22, 2023 Today, the U.S. Food and Drug Administration released new educational materials for patients related to biosimilars and…
MS Drug Therapies

March 5, 2023

Breakthrough COVID-19 Vaccine Injury Study Links mRNA Vaccines to Triggering Autoimmune Diseases

  • #COVID-19
    /
TrialSite Staff Staff at TrialSite | Quality Journalism Mar. 4, 2023, 2:00 p.m. Physician-investigators at King Fahad University Hospital in…
#COVID-19

March 4, 2023

Diet can be a ‘proactive’ way to engage patients with MS in their long-term care

  • Multiple Sclerosis
    /
  • Nutrition
    /
 March 03, 2023 SAN DIEGO — Physicians should emphasize the importance of diet and lifestyle change in patients with MS…
Multiple Sclerosis

March 4, 2023

Your brain could be controlling how sick you get — and how you recover

  • Misc. MS Related
    /
 February 22, 2023           – by: Diana Kwon Scientists are deciphering how the brain choreographs immune responses, hoping…
Misc. MS Related

March 3, 2023

Role of the Comprehensive Care Team

  • Additional MS resource sites
    /
 source:  The Consortium of Multiple Sclerosis Centers The world of multiple sclerosis has changed during the past two decades. There…
Additional MS resource sites

March 2, 2023

Register for Virtual MS WELLNESS event – taking place on March 18th

  • MS Diet & Nutrition
    /
  • MS Educational Programs
    /
  • MS PODCASTS
    /
  • Multiple Sclerosis
    /
March is MS Awareness Month. Let’s take this opportunity to raise awareness about living with MS! Through having a better…
MS Diet & Nutrition

March 2, 2023

Are you on a Biologic Medication? What you need to know about biosimilar treatment options.

  • Misc. MS Related
    /
  • MS Drug Therapies
    /
  • MS Specialty Pharmacy
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
—————– Vea esta página en español The Food and Drug Administration (FDA) has approved many biologics (also called biological products),…
Misc. MS Related

March 1, 2023

Astrocyte receptors may help to ease MS cognitive issues – presented at ACTRIMS 2023

  • Memory (Cognition)
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
 by Lindsey Shapiro, PhD | February 28, 2023  MS mouse models genetically engineered to lack these receptors, called TNFR2, showed…
Memory (Cognition)

March 1, 2023

FDA Approves Tascenso ODT® (fingolimod), similar to Gilenya, for Relapsing MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
 February 21, 2023 The U.S. Food and Drug Administration recently approved Tascenso ODT® (fingolimod, Cycle Pharmaceuticals) as an orally disintegrating tablet…
MS Drug Therapies

February 28, 2023

Octave Presents Data from Nine Company and Partner Abstracts at ACTRIMS Forum 2023 on MSDA and more

  • Digital Therapeutics
    /
  • MRI
    /
  • MS Research Study and Reports
    /
 Real-world data sets show components of value-based care, use of Octave’s Multiple Sclerosis Disease Activity test and deep scan biomarker…
Digital Therapeutics

Categories

Latest Blog Posts